Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection
- Snell, Luke Blagdon
- Alcolea-Medina, Adela
- Charalampous, Themis
- Alder, Christopher
- Williams, Tom G.S.
- Flaviani, Flavia
- Batra, Rahul
- Bakrania, Prijay
- Thangarajah, Rajeni
- Neil, Stuart
- van Nispen tot Pannerden, Claire
- Botgros, Alina
- Aarons, Emma J.
- Douthwaite, Sam T
- Edgeworth, Jonathan
- Nebbia, Gaia
DOIAbstract
The management of COVID-19 has become more complex due to the expansion of available therapies. The presence of SARS-CoV-2 variants and mutations further complicate treatment due to their differing susceptibilities to therapies. Here we outline the use of real-time whole genome sequencing to characterise infections and guide treatment decisions
Add to ORKG